Endolytix
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- endolytx.bio
- Total Funding
- $9.3M
- Last Round
- $5.0M Growth EquityOct 2024
- Rounds
- 3
About
Biotech company developing novel therapeutics to treat antibiotic-resistant infections, with a focus on non-tuberculous mycobacterial (NTM) disease.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Oct 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.